{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:16:59Z","timestamp":1788261419753,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.clinre.2017.09.001","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T17:36:45Z","timestamp":1507829805000},"page":"118-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats"],"prefix":"10.1016","volume":"42","author":[{"given":"Chi-Hao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Sheng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinre.2017.09.001_bib0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clinre.2016.11.010","article-title":"Intrahepatic upregulation of MRTF-A signaling contributes to increased hepatic vascular resistance in cirrhotic rats with portal hypertension","volume":"41","author":"Zheng","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinre.2017.09.001_bib0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/imj.12590","article-title":"Portal hypertension: pathophysiology, diagnosis and management","volume":"45","author":"Bloom","year":"2015","journal-title":"Intern Med J"},{"key":"10.1016\/j.clinre.2017.09.001_bib0170","first-page":"4612769","volume":"2017","author":"Tian","year":"2017","journal-title":"Carvedilol attenuates the progression of hepatic fibrosis induced by bile duct ligation"},{"issue":"10","key":"10.1016\/j.clinre.2017.09.001_bib0175","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3748\/wjg.v20.i10.2515","article-title":"Hepatic inflammation and progressive liver fibrosis in chronic liver disease","volume":"20","author":"Czaja","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.clinre.2017.09.001_bib0180","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00210-016-1210-1","article-title":"Gingerol protects against experimental liver fibrosis in rats via suppression of pro-inflammatory and profibrogenic mediators","volume":"389","author":"Algandaby","year":"2016","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"issue":"2","key":"10.1016\/j.clinre.2017.09.001_bib0185","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/jgh.12718","article-title":"Long-term lamivudine treatment achieves regression of advanced liver fibrosis\/cirrhosis in patients with chronic hepatitis B","volume":"30","author":"Xu","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2017.09.001_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2017.03.007","article-title":"Inhibition of soluble epoxide hydrolase reduces portal pressure by protecting mesenteric artery myogenic responses in cirrhotic rats","author":"Huang","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.clinre.2017.09.001_bib0195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fphar.2014.00216","article-title":"Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury","volume":"5","author":"Khan","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clinre.2017.09.001_bib0200","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.prostaglandins.2016.05.004","article-title":"EETs\/sEH in diabetes and obesity-induced cardiovascular diseases","volume":"125","author":"Huang","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"2","key":"10.1016\/j.clinre.2017.09.001_bib0205","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1152\/ajpendo.00366.2014","article-title":"CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice","volume":"308","author":"Chen","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.clinre.2017.09.001_bib0210","doi-asserted-by":"crossref","first-page":"e39165","DOI":"10.1371\/journal.pone.0039165","article-title":"Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice","volume":"7","author":"Liu","year":"2012","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.clinre.2017.09.001_bib0215","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/jpet.110.167544","article-title":"Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis","volume":"334","author":"Luo","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.clinre.2017.09.001_bib0220","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.taap.2015.03.022","article-title":"Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice","volume":"286","author":"Harris","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"10.1016\/j.clinre.2017.09.001_bib0225","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/ijms17040455","article-title":"Liver fibrosis in HCV monoinfected and HIV\/HCV coinfected patients: dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors","volume":"17","author":"Latronico","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"125","key":"10.1016\/j.clinre.2017.09.001_bib0230","first-page":"81","article-title":"Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K\/AKT\/mTOR\/p70S6K1 signaling pathways","volume":"23","author":"Peng","year":"2017","journal-title":"Discov Med"},{"issue":"4\u00a0Pt\u00a01","key":"10.1016\/j.clinre.2017.09.001_bib0235","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/jhep.2002.35625","article-title":"Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse","volume":"36","author":"Yoshiji","year":"2002","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2017.09.001_bib0240","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.20425","article-title":"Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats","volume":"40","author":"Parsons","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2017.09.001_bib0245","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijcard.2011.12.062","article-title":"Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction","volume":"167","author":"Kompa","year":"2013","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.clinre.2017.09.001_bib0250","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1089\/hum.2011.135","article-title":"Delivery of AAV2-CYP2J2 protects remnant kidney in the 5\/6-nephrectomized rat via inhibition of apoptosis and fibrosis","volume":"23","author":"Zhao","year":"2012","journal-title":"Hum Gene Ther"},{"issue":"2","key":"10.1016\/j.clinre.2017.09.001_bib0255","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00441-015-2262-0","article-title":"Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"363","author":"Zhou","year":"2016","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.clinre.2017.09.001_bib0260","first-page":"6303","article-title":"Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-kappaB\/IkappaBalpha, and Bcl-2\/Bax signaling","volume":"9","author":"Wang","year":"2015","journal-title":"Drug Design Dev Ther"},{"issue":"3","key":"10.1016\/j.clinre.2017.09.001_bib0265","doi-asserted-by":"crossref","first-page":"C278","DOI":"10.1152\/ajpcell.00386.2011","article-title":"Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor","volume":"303","author":"Sanders","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"issue":"9","key":"10.1016\/j.clinre.2017.09.001_bib0270","doi-asserted-by":"crossref","first-page":"e75107","DOI":"10.1371\/journal.pone.0075107","article-title":"Inducible CYP2J2 and its product 11,12-EET promotes bacterial phagocytosis: a role for CYP2J2 deficiency in the pathogenesis of Crohn's disease?","volume":"8","author":"Bystrom","year":"2013","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.clinre.2017.09.001_bib0275","doi-asserted-by":"crossref","first-page":"F971","DOI":"10.1152\/ajprenal.00256.2014","article-title":"Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation","volume":"307","author":"Kim","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.clinre.2017.09.001_bib0280","doi-asserted-by":"crossref","first-page":"693260","DOI":"10.1155\/2015\/693260","article-title":"Genetic deletion of soluble epoxide hydrolase attenuates inflammation and fibrosis in experimental obstructive nephropathy","volume":"2015","author":"Chiang","year":"2015","journal-title":"Mediat Inflamm"},{"issue":"3","key":"10.1016\/j.clinre.2017.09.001_bib0285","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/jpet.116.232108","article-title":"Anti-ulcer efficacy of soluble epoxide hydrolase inhibitor TPPU on diclofenac-induced intestinal ulcers","volume":"357","author":"Goswami","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.clinre.2017.09.001_bib0290","doi-asserted-by":"crossref","first-page":"e0148868","DOI":"10.1371\/journal.pone.0148868","article-title":"Carvedilol improves inflammatory response, oxidative stress and fibrosis in the alcohol-induced liver injury in rats by regulating kuppfer cells and hepatic stellate cells","volume":"11","author":"Araujo Junior","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.clinre.2017.09.001_bib0295","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.etap.2016.05.033","article-title":"Betaine treatment decreased oxidative stress, inflammation, and stellate cell activation in rats with alcoholic liver fibrosis","volume":"45","author":"Bingul","year":"2016","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"10.1016\/j.clinre.2017.09.001_bib0300","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.taap.2010.11.016","article-title":"Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice","volume":"251","author":"Ghatak","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"10.1016\/j.clinre.2017.09.001_bib0305","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1159\/000362950","article-title":"CYP2J2 and EETs protect against oxidative stress and apoptosis in vivo and in vitro following lung ischemia\/reperfusion","volume":"33","author":"Chen","year":"2014","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"10.1016\/j.clinre.2017.09.001_bib0310","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1258\/ebm.2011.011358","article-title":"Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence","volume":"237","author":"Zhu","year":"2012","journal-title":"Exp Biol Med"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740117301870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740117301870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:25:46Z","timestamp":1761895546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740117301870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S2210740117301870"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2017.09.001","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2017.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}